z-logo
open-access-imgOpen Access
Efficacy and safety of palbociclib plus endocrine therapy for patients with HR+/HER2− advanced breast cancer in real-world clinical practice
Author(s) -
Bingqian Zhong,
Jie Zhang,
Jing Wu,
Langshuang Sun,
Shuhong Li,
Xiaohua Zeng,
Lu Gan
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-1002
Subject(s) - palbociclib , medicine , oncology , clinical endpoint , metastatic breast cancer , breast cancer , progression free survival , cancer , gynecology , clinical trial , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom